Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Engeli, S.
Right arrow Articles by Sharma, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engeli, S.
Right arrow Articles by Sharma, A. M.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:942-947, 2003
© 2003 by the American Diabetes Association, Inc.

Association Between Adiponectin and Mediators of Inflammation in Obese Women

Stefan Engeli1, Mareike Feldpausch1, Kerstin Gorzelniak1, Frauke Hartwig1, Ute Heintze1, Jürgen Janke1, Matthias Möhlig2, Andreas F.H. Pfeiffer2, Friedrich C. Luft1, and Arya M. Sharma1,3

1 HELIOS Klinikum Berlin, Franz Volhard Clinic, Medical Faculty of the Charité, Humboldt University of Berlin, and Max Delbrück Center for Molecular Medicine, Berlin, Germany
2 German Institute of Human Nutrition, Potsdam-Rehbrücke, Germany
3 Department of Internal Medicine, McMaster University, Hamilton, Ontario, Canada

Low plasma levels of the anti-inflammatory factor adiponectin characterize obesity and insulin resistance. To elucidate the relationship between plasma levels of adiponectin, adiponectin gene expression in adipose tissue, and markers of inflammation, we obtained blood samples, anthropometric measures, and subcutaneous adipose tissue samples from 65 postmenopausal healthy women. Adiponectin plasma levels and adipose-tissue gene expression were significantly lower in obese subjects and inversely correlated with obesity-associated variables, including high-sensitive C-reactive protein (hs-CRP) and interleukin-6 (IL-6). Despite adjustment for obesity-associated variables, plasma levels of adiponectin were significantly correlated to adiponectin gene expression (partial r = 0.38, P < 0.05). Furthermore, the inverse correlation between plasma levels of hs-CRP and plasma adiponectin remained significant despite correction for obesity-associated variables (partial r = -0.32, P < 0.05), whereas the inverse correlation between adiponectin plasma levels or adiponectin gene expression in adipose tissue with plasma IL-6 were largely dependent on the clustering of obesity-associated variables. In conclusion, our data suggest a transcriptional mechanism leading to decreased adiponectin plasma levels in obese women and demonstrate that low levels of adiponectin are associated with higher levels of hs-CRP and IL-6, two inflammatory mediators and markers of increased cardiovascular risk.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Diabetes CareHome page
W. A. Banks, L. M. Willoughby, D. R. Thomas, and J. E. Morley
Insulin Resistance Syndrome in the Elderly: Assessment of functional, biochemical, metabolic, and inflammatory status
Diabetes Care, September 1, 2007; 30(9): 2369 - 2373.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
A. E Schutte, H. W Huisman, R. Schutte, L. Malan, J. M van Rooyen, N. T Malan, and P. E H Schwarz
Differences and similarities regarding adiponectin investigated in African and Caucasian women
Eur. J. Endocrinol., August 1, 2007; 157(2): 181 - 188.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Engeli, M. Boschmann, F. Adams, G. Franke, K. Gorzelniak, J. Janke, F. C. Luft, and J. Jordan
Dissociation between Adipose Nitric Oxide Synthase Expression and Tissue Metabolism
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2706 - 2711.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. Wiecek, M. Adamczak, and J. Chudek
Adiponectin--an adipokine with unique metabolic properties
Nephrol. Dial. Transplant., April 1, 2007; 22(4): 981 - 988.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
R. Wolk, P. Berger, R. J. Lennon, E. S. Brilakis, D. E. Davison, and V. K. Somers
Association between plasma adiponectin levels and unstable coronary syndromes
Eur. Heart J., February 1, 2007; 28(3): 292 - 298.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
S. A. Shore
Obesity and asthma: lessons from animal models
J Appl Physiol, February 1, 2007; 102(2): 516 - 528.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Abbasi, H. M. F. Farin, C. Lamendola, T. McLaughlin, E. A. Schwartz, G. M. Reaven, and P. D. Reaven
The Relationship between Plasma Adiponectin Concentration and Insulin Resistance Is Altered in Smokers
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5002 - 5007.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
K. Matsushita, Y. Wu, Y. Okamoto, R. E. Pratt, and V. J. Dzau
Local Renin Angiotensin Expression Regulates Human Mesenchymal Stem Cell Differentiation to Adipocytes
Hypertension, December 1, 2006; 48(6): 1095 - 1102.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. Janke, S. Engeli, M. Boschmann, F. Adams, J. Bohnke, F. C. Luft, A. M. Sharma, and J. Jordan
Retinol-binding protein 4 in human obesity.
Diabetes, October 1, 2006; 55(10): 2805 - 2810.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
J George, S Patal, D Wexler, Y Sharabi, E Peleg, Y Kamari, E Grossman, D Sheps, G Keren, and A Roth
Circulating adiponectin concentrations in patients with congestive heart failure
Heart, October 1, 2006; 92(10): 1420 - 1424.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
K. Kantartzis, K. Rittig, B. Balletshofer, J. Machann, F. Schick, K. Porubska, A. Fritsche, H.-U. Haring, and N. Stefan
The Relationships of Plasma Adiponectin with a Favorable Lipid Profile, Decreased Inflammation, and Less Ectopic Fat Accumulation Depend on Adiposity
Clin. Chem., October 1, 2006; 52(10): 1934 - 1942.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
C. Herder, H. Hauner, B. Haastert, K. Rohrig, W. Koenig, H. Kolb, S. Muller-Scholze, B. Thorand, R. Holle, and W. Rathmann
Hypoadiponectinemia and Proinflammatory State: Two Sides of the Same Coin?: Results From the Cooperative Health Research in the Region of Augsburg Survey 4 (KORA S4)
Diabetes Care, July 1, 2006; 29(7): 1626 - 1631.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. von Eynatten, A. Hamann, D. Twardella, P. P. Nawroth, H. Brenner, and D. Rothenbacher
Relationship of Adiponectin with Markers of Systemic Inflammation, Atherogenic Dyslipidemia, and Heart Failure in Patients with Coronary Heart Disease
Clin. Chem., May 1, 2006; 52(5): 853 - 859.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. M. Bruun, J. W. Helge, B. Richelsen, and B. Stallknecht
Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects
Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E961 - E967.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
A. Oberbach, A. Tonjes, N. Kloting, M. Fasshauer, J. Kratzsch, M. W Busse, R. Paschke, M. Stumvoll, and M. Bluher
Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance.
Eur. J. Endocrinol., April 1, 2006; 154(4): 577 - 585.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. A. Quyyumi
Women and Ischemic Heart Disease: Pathophysiologic Implications From the Women's Ischemia Syndrome Evaluation (WISE) Study and Future Research Steps
J. Am. Coll. Cardiol., February 7, 2006; 47(3_Suppl_S): S66 - S71.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
F. Haugen, T. Ranheim, N. K. Harsem, E. Lips, A. C. Staff, and C. A. Drevon
Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression
Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E326 - E333.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. G. Schalkwijk, N. Chaturvedi, M. T. Schram, J. H. Fuller, C. D. A. Stehouwer, and the EURODIAB Prospective Complications Study Group
Adiponectin Is Inversely Associated with Renal Function in Type 1 Diabetic Patients
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 129 - 135.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. Spranger, S. Verma, I. Gohring, T. Bobbert, J. Seifert, A. L. Sindler, A. Pfeiffer, S. M. Hileman, M. Tschop, and W. A. Banks
Adiponectin Does Not Cross the Blood-Brain Barrier but Modifies Cytokine Expression of Brain Endothelial Cells
Diabetes, January 1, 2006; 55(1): 141 - 147.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. R. Manigrasso, P. Ferroni, F. Santilli, T. Taraborelli, M. T. Guagnano, N. Michetti, and G. Davi
Association between Circulating Adiponectin and Interleukin-10 Levels in Android Obesity: Effects of Weight Loss
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5876 - 5879.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Engeli, J. Bohnke, M. Feldpausch, K. Gorzelniak, J. Janke, S. Batkai, P. Pacher, J. Harvey-White, F. C. Luft, A. M. Sharma, et al.
Activation of the Peripheral Endocannabinoid System in Human Obesity
Diabetes, October 1, 2005; 54(10): 2838 - 2843.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. Kistorp, J. Faber, S. Galatius, F. Gustafsson, J. Frystyk, A. Flyvbjerg, and P. Hildebrandt
Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure
Circulation, September 20, 2005; 112(12): 1756 - 1762.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P. J. Klover, A. H. Clementi, and R. A. Mooney
Interleukin-6 Depletion Selectively Improves Hepatic Insulin Action in Obesity
Endocrinology, August 1, 2005; 146(8): 3417 - 3427.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. Boschmann, S. Engeli, F. Adams, K. Gorzelniak, G. Franke, S. Klaua, U. Kreuzberg, S. Luedtke, R. Kettritz, A. M. Sharma, et al.
Adipose Tissue Metabolism and CD11b Expression on Monocytes in Obese Hypertensives
Hypertension, July 1, 2005; 46(1): 130 - 136.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Saraheimo, C. Forsblom, J. Fagerudd, A.-M. Teppo, K. Pettersson-Fernholm, J. Frystyk, A. Flyvbjerg, P.-H. Groop, and on behalf of the FinnDiane Study Group
Serum Adiponectin Is Increased in Type 1 Diabetic Patients With Nephropathy
Diabetes Care, June 1, 2005; 28(6): 1410 - 1414.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Otake, H. Takeda, Y. Suzuki, T. Fukui, S. Watanabe, K. Ishihama, T. Saito, H. Togashi, T. Nakamura, Y. Matsuzawa, et al.
Association of Visceral Fat Accumulation and Plasma Adiponectin with Colorectal Adenoma: Evidence for Participation of Insulin Resistance
Clin. Cancer Res., May 15, 2005; 11(10): 3642 - 3646.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
G. de Simone, K. Wachtell, V. Palmieri, D. A. Hille, G. Beevers, B. Dahlof, U. de Faire, F. Fyhrquist, H. Ibsen, S. Julius, et al.
Body Build and Risk of Cardiovascular Events in Hypertension and Left Ventricular Hypertrophy: The LIFE (Losartan Intervention For Endpoint reduction in hypertension) Study
Circulation, April 19, 2005; 111(15): 1924 - 1931.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
M.-T. Berthier, A. Houde, M. Cote, A.-M. Paradis, P. Mauriege, J. Bergeron, D. Gaudet, J.-P. Despres, and M.-C. Vohl
Impact of adiponectin gene polymorphisms on plasma lipoprotein and adiponectin concentrations of viscerally obese men
J. Lipid Res., February 1, 2005; 46(2): 237 - 244.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. G. Kaditis, E. I. Alexopoulos, E. Kalampouka, E. Kostadima, A. Germenis, E. Zintzaras, and K. Gourgoulianis
Morning Levels of C-Reactive Protein in Children with Obstructive Sleep-disordered Breathing
Am. J. Respir. Crit. Care Med., February 1, 2005; 171(3): 282 - 286.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
F. Guebre-Egziabher, J. Bernhard, T. Funahashi, A. Hadj-Aissa, and D. Fouque
Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function
Nephrol. Dial. Transplant., January 1, 2005; 20(1): 129 - 134.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
S. Engeli, J. Janke, K. Gorzelniak, J. Bohnke, N. Ghose, C. Lindschau, F. C. Luft, and A. M. Sharma
Regulation of the nitric oxide system in human adipose tissue
J. Lipid Res., September 1, 2004; 45(9): 1640 - 1648.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. B. Schulze, E. B. Rimm, I. Shai, N. Rifai, and F. B. Hu
Relationship Between Adiponectin and Glycemic Control, Blood Lipids, and Inflammatory Markers in Men With Type 2 Diabetes
Diabetes Care, July 1, 2004; 27(7): 1680 - 1687.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
A. M. Sharma
Is There a Rationale for Angiotensin Blockade in the Management of Obesity Hypertension?
Hypertension, July 1, 2004; 44(1): 12 - 19.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. Tauman, A. Ivanenko, L. M. O'Brien, and D. Gozal
Plasma C-Reactive Protein Levels Among Children With Sleep-Disordered Breathing
Pediatrics, June 1, 2004; 113(6): e564 - e569.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
J. N. Fain, A. K. Madan, M. L. Hiler, P. Cheema, and S. W. Bahouth
Comparison of the Release of Adipokines by Adipose Tissue, Adipose Tissue Matrix, and Adipocytes from Visceral and Subcutaneous Abdominal Adipose Tissues of Obese Humans
Endocrinology, May 1, 2004; 145(5): 2273 - 2282.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
B. Pilz, J.-H. Brasen, W. Schneider, and F. C. Luft
Obesity and Hypertension-Induced Restrictive Cardiomyopathy: A Harbinger of Things to Come
Hypertension, May 1, 2004; 43(5): 911 - 917.
[Full Text] [PDF]

Home page
 JAMAHome page
T. Pischon, C. J. Girman, G. S. Hotamisligil, N. Rifai, F. B. Hu, and E. B. Rimm
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men
JAMA, April 14, 2004; 291(14): 1730 - 1737.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
J. N. Fain, S. W. Bahouth, and A. K. Madan
Haptoglobin release by human adipose tissue in primary culture
J. Lipid Res., March 1, 2004; 45(3): 536 - 542.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
J. T. Lane
Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective
Am J Physiol Renal Physiol, March 1, 2004; 286(3): F442 - F450.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Iacobellis, M. C. Ribaudo, F. Assael, E. Vecci, C. Tiberti, A. Zappaterreno, U. Di Mario, and F. Leonetti
Echocardiographic Epicardial Adipose Tissue Is Related to Anthropometric and Clinical Parameters of Metabolic Syndrome: A New Indicator of Cardiovascular Risk
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5163 - 5168.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. J. Klover, T. A. Zimmers, L. G. Koniaris, and R. A. Mooney
Chronic Exposure to Interleukin-6 Causes Hepatic Insulin Resistance in Mice
Diabetes, November 1, 2003; 52(11): 2784 - 2789.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. S. Lihn, B. Richelsen, S. B. Pedersen, S. B. Haugaard, G. S. Rathje, S. Madsbad, and O. Andersen
Increased expression of TNF-{alpha}, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels
Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E1072 - E1080.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.